JSM Sexual Medicine

Prevalence of Congenital Syphilis in a Hospital in Bogotá in 2014 and 25 Years Before

Research Article | Open Access

  • 1. Department of Pediatrics, National University of Colombia, Colombia
  • 2. San Ignacio University Hospital, Bogotá, Colombia
+ Show More - Show Less
Corresponding Authors
Yolanda Cifuentes Cifuentes, Department of Pediatrics, Division of Neonatology, National University of Colombia, Bogota DC, Colombia, Email: mycifuentesd@unal.edu.co

Objectives: The objective of this study is to compare the results of the syphilis screening program in force in 2014 with the results of the screening program at the time of delivery implemented 25 years ago at the Maternal and Child Institute (IMI) of Bogotá.

Methodology: Retrospective descriptive study, where the medical records of pregnant women with reactive VDRL at the time of delivery who were diagnosed with gestational syphilis were identified, with the subsequent review of the medical records of the corresponding newborns to evaluate the concordance of the diagnosis. Mother-child and manifestations in the newborn.

Results: During the first semester of 2014, the IMI received 2,141 births, 27 mothers had gestational syphilis and 18 of the newborns were cases of congenital syphilis: 2 stillborn and 16 alive, 100% of whom had some sign or symptom compatible with congenital syphilis. When compared with the results obtained in 1989, statistically significant differences were found in neonatal mortality due to CS, in the frequency of premature babies and in the evident manifestations in the physical examination showing a less severe disease; there were also differences in the VDRL titers of mothers and newborns when compared with the results obtained in 1989.

Discussion and conclusions: 25 years ago, at the IMI, a study was carried out on the behavior of gestational and congenital syphilis in our country, finding a prevalence of 0.719%.


Congenital syphilis, fetal mortality, neonatal mortality, neurosyphilis


Cifuentes-Cifuentes Y, Muñoz-Ramírez KJ (2022) Prevalence of Congenital Syphilis in a Hospital in Bogotá in 2014 and 25 Years Before. JSM Sexual Med 6(3): 1091.


Syphilis is a worldwide public health problem [1]; infection in pregnant women can cause fetal infection that can result in preterm birth, growth restriction, asymptomatic newborns, systemic infection, hydrops, abortions, stillbirths and neonatal mortality [2,3].

The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study reported that congenital syphilis was among the top ten causes of DALYs (disability-adjusted life-years) in children under the age of 10 years in 2019 [4].

In 2016, the estimated global prevalence of GS was 4.73 cases per 1,000 births with a total of 661,000 cases of CS corresponding to 143,000 cases of abortions and stillbirths (21.6%) and 518,000 newborns with congenital syphilis (78.4 %) [5]. Estimated prevalence and incidence vary by region or country, with the highest prevalence and burden of maternal syphilis occurring in Africa, with more than 60% of new cases occurring in low- and middle-income countries [6].

In the United States for the year 2000 the incidence of syphilis in the general population was 2.1 x 100,000 inhabitants and for 2011-2013 it was 5.3 cases per 100,000 inhabitants; this increase occurred mainly in men between 20 and 29 years of age who had sex with men [7]. For 2016, the CDC reports an incidence of 27.3 x 100,000 inhabitants with an increase to 40.8 x 100,000 inhabitants in 2020, with women being the second affected population [8].

In Canada, from 2010 to 2015, the incidence of syphilis increased from 5.0 to 9.3 cases per 100,000 inhabitants, more frequent in men, 17.5 cases per 100,000 men vs 1.2 per 100,000 women [9].

In Latin America, in the state of Sao Paulo in Brazil, where syphilis in the general population is mandatory to report, between 2011 and 2017, an increase of 26.0 to 84.6 x 100,000 inhabitants was reported and in pregnant women, an increase of 33.7 to 108.9 [10].

Since 2003, cases of gestational syphilis and congenital syphilis have been reported in Colombia; An increase has been reported between 2016 and 2022 in gestational syphilis, going from 6.2 cases per 1,000 live births (LB) + stillbirths to 16.8 x 1,000 LB + stillbirths, and for congenital syphilis from 1.2 to 2.6 cases per 1,000 LB + stillbirths [11].

Women with syphilis during pregnancy have a higher risk of stillbirth or low birth weight (OR 4.1, 95% CI: 2.4 to 7.2); With prenatal treatment, the outcome of pregnancy improves significantly, even so the risk of an adverse outcome remains 2.5 times higher than that observed in uninfected pregnant women [12].

Adequate treatment in pregnant women includes administration of PNB according to the recommended regimen for the stage of infection administered 30 days or more before delivery, expected decrease in VDRL titer, and treatment of contact(s). In Colombia, according to the Clinical Practice Guideline [13], the treatment of pregnant women with early syphilis (less than or equal to 1 year of infection) is 2,400,000 IU of PNB IM in a single dose; for late syphilis (latent syphilis lasting more than 1 year since infection) and for syphilis of unknown duration, 2,400,000 IU of PNB IM weekly dose for 3 weeks; The criteria to consider a case of CS include a live or dead newborn born to a mother with gestational syphilis without treatment or with inadequate treatment to prevent congenital syphilis OR all newborns with a non-treponemal test (VDRL, RPR) with titers four times higher than the titers of the mother at the time of delivery OR all newborns born to pregnant women with a diagnosis of syphilis in the current pregnancy, with one or more manifestations suggestive of congenital syphilis on physical examination or with suggestive paraclinical tests of congenital syphilis OR All fruit of pregnancy with demonstration of Treponema pallidum by some specific procedure. The treatment of the case of SC should be done with IV Crystalline Penicillin for ten days [13]. with one or several manifestations suggestive of congenital syphilis on physical examination or with paraclinical tests suggestive of congenital syphilis OR All fruit of pregnancy with demonstration of Treponema pallidum by some specific procedure. The treatment of the case of SC should be done with IV Crystalline Penicillin for ten days [13]. with one or several manifestations suggestive of congenital syphilis on physical examination or with paraclinical tests suggestive of congenital syphilis OR All fruit of pregnancy with demonstration of Treponema pallidum by some specific procedure. The treatment of the case of SC should be done with IV Crystalline Penicillin for ten days [13].

The present work describes the epidemiological behavior of gestational and congenital syphilis in the population treated at Hospital La Victoria, headquarters of the Maternal and Child Institute, during the first semester of 2014, comparing it with the results obtained 25 years ago and reviews the impact that on the Institution have had public health policies implemented in recent years regarding the prevention, diagnosis and management of this pathology in populations at risk.


This is a retrospective descriptive study, developed at La Victoria Hospital, headquarters of the Maternal and Child Institute, a third-level center where pregnant women and their newborns are cared for. All births occurring from January 1, 2014 to June 30 of the same year were included; The medical records of pregnant women with reactive VDRL at the time of delivery were identified, ruling out false positive cases. In cases with a confirmed diagnosis of gestational syphilis, it was evaluated whether the patient received appropriate and timely pharmacological management and whether it was successful. Subsequently, the records of the corresponding newborns were reviewed to evaluate the Mother-Child concordance regarding the diagnosis of Syphilis, the manifestations presented by the newborn and the VDRL values found;

Inclusion criteria

Pregnant women attended at the time of delivery at the Maternal and Child Institute during the first semester (January 1 to June 30) of 2014, with a reactive VDRL result and a positive treponemal test, and their corresponding newborns.

Exclusion criteria

Pregnant women with a reactive non-treponemal test and a negative treponemal test or with an incomplete or unavailable clinical history.

The information processing was done with the statistical processor Programming and Data Management (SPSS) version 15.0 for Windows. The percentage was used as a summary measure to present the results of the variables used. To determine the correlation between the variables, the Chi-square test was used and a value of P<0.05 was considered as the level of statistical significance. The presentation of the information was done through tables.


During the study period between January 1 and June 30, 2014, 2,141 births were received, corresponding to 2,135 live newborns and 6 stillbirths; In 1989, 1,668 births were attended, corresponding to 1,610 live births and 58 stillbirths, the difference in fetal mortality in the two populations attended is very significant (P less than 0.0001).

In 2014, a record was found of 42 pregnant women with reactive VDRL at the time of delivery, of which 4 were excluded due to non-availability of medical records and 11 that corresponded to false positives due to having a negative treponemal test (FTAAbs). The remaining 27 patients were classified as confirmed cases of gestational syphilis. When reviewing the records corresponding to pregnant women with confirmed cases of gestational syphilis and those of their newborns, it was found that 12 pregnant women with a diagnosis of a confirmed case of gestational syphilis received adequate treatment during pregnancy, considering successful treatment to prevent CS in 9 patients.

During the study period, a report was found of 4 patients who had an abortion between week 6 and week 9 of gestation, with reactive VDRL at the time of admission to the hospital, 2 of whom met the criteria for the diagnosis of gestational syphilis without treatment at the time of loss.

Table 1: Characteristics of CS cases, 2014.
C# Weight(g) EG Weight/GA Sex NOC Findings VDRL RN VDRL CSF VDRL stem mother treatment
1 2900 39 Appropriate M two Elevated transaminases. proteinuria 1:8 NR 1:64 without treatment
2 2850 37 Appropriate M 1 Elevated transaminases. proteinuria 1:1 NR 1:4 without treatment
3 3150 38 Appropriate M 8 Elevated transaminases. proteinuria 1:2 NR 1:4 without treatment
4 2980 38 Appropriate M 0 Proteinorrhachia 1:2 NR 1:2 without treatment
5 2380 36 Appropriate M 1 Prematurity 1:32 NR 1:32 without treatment
6 2250 39 Bass F 0 IUGR 1:16 - 1:32 without treatment
7 2100 38 Bass M 0 IUGR 1:1 - 1:4 without treatment
8 1700 36 Bass M 0 Prematurity, IUGR, elevated transaminases 1:8 NR 1:32 without treatment
9 2890 38 Appropriate F 7 Pleocytosis 1:8 NR 1:16 Inadequate
10 3100 38 Appropriate F 3 elevated transaminases. proteinuria 1:1 NR 1:0 Inadequate
11 2950 40 Appropriate M 5 Proteinorrhachia NR NR 1:0 Inadequate
12 2400 38 Bass M 4 IUGR NR NR 1:0 Inadequate
13 3000 40 Appropriate M 6 Proteinorrhachia 1:4 NR 1:8 Inadequate
14 3900 40 Appropriate M 3 elevated transaminases 1:0 - 1:0 Failure
15 3100 40 Appropriate M 7 elevated transaminases. proteinuria 1:0 NR 1:2 Failure
16 2250 37 Bass F 3 elevated transaminases. Proteinuria, hematuria.IUGR 1:4 NR 1:8 Failure

Of the 18 cases that met the criteria to be considered cases of congenital syphilis, 2 were stillbirths and 16 corresponded to live newborns with a frequency of the disease of 1 for every 133 live births and 1 for every 3 stillbirths; In 1989, 12 cases were found, of which 5 were stillbirths and 7 were live births, with a disease frequency of 1 per 230 live births and 1 per 12 stillbirths (27); these differences are not statistically significant (P 0.0837). The characteristics of live newborns with CS are shown in Tables 1 and 2.

Table 2: Characteristics of CS cases, 1989.
Case Weight EG WeightxEG NOC Manifestations and complications VDRL RN VDRL CSF VDRL stem pass away Diagnosis in childbirth
1 2200 36 AEG No none 1:512 not r 1:64 No Yes
2 820 30 IUGR No Palmoplantar desquamation, hepatosplenomegaly, RDS, pneumothorax 1:16 ? 1:256 Yes Yes
3 2600 40 IUGR ? none 1:128 1:2 1:32 No Yes
4 1140 32 IUGR No hepatosplenomegaly, periostitis, gastrointestinal bleeding 1:512 1:2 1:32 Yes Yes
5 1550 32 AEG No Splenomealia, severe jaundice, bacterial meningitis 1:128 1:1 1:64   Yes
6 3330 40 AEG ? none 1:64 1:2 1:16 No Yes
7 1320 32 AEG Yes Palmoplantar pemphigus, ascites, hepatosplenomegaly, pneumonia alba, asphyxia, shock ? ? 1:8 Yes Yes

Of the 16 cases of live newborns with CS, 50% of pregnant women with SG (8 pregnant women) did not receive treatment, of the rest (9 pregnant women), 6 received inadequate treatment and 3 cases were considered treatment failure to prevent CS due to no evidence of a decrease in VDRL titers, absence of treatment for the partner and findings compatible with CS in the newborns.

Of the 16 cases of live births, none died, which contrasts with the mortality of the cases of the 1989 study in which 4 of the 7 live births with CS died, this difference is statistically significant (P 0.0040).

Regarding the characteristics of NBs with CS, in 2014 of the 16 cases of CS, 2 were preterm (<37 weeks) and 5 had IUGR, in 1989, of 7 cases, 5 were preterm and 3 had IUGR, the difference in the frequency of prematurity is statistically significant (P 0.0107), the difference in the frequency of intrauterine growth restriction is not significant (p0.6570).

In 2014, none presented the clinical manifestations evident in the physical examination or bone alterations described in the 1989 cases, 50% (8 cases) had liver involvement, 37.5% (6 cases) had kidney involvement and 25% (4 cases) had CSF cytochemical abnormalities but none had reactive CSF VDRL; When comparing these results with those found in 1989, a similarity is observed in the tendency to liver involvement.

In the 2014 study none of 13 cases of CS newborns who underwent lumbar puncture had reactive CSF VDRL, in 1989, 4 patients out of 5 had reactive CSF VDRL, this difference is statistically significant (P 0.0016)

From the point of view of the serological test titers comparing those of the newborn with those of the mother, in 2014 in 3 cases the VDRL of the newborn was equal to or > the VDRL of the mother, in 1989 in 5 of 6 VDRL of the newborn was equal to or > the mother’s VDRL, this difference is statistically significant (P 0.0109)

In 2014, 7 pregnant women had VDRL >= 8 dilutions, in 1989 the 7 pregnant women had VDRL titers >= 8 dilutions, this difference is statistically significant (P 0.0074)

In pregnant women who had stillbirths, when comparing VDRL titers in 2014, 1 pregnant woman had VDRL >=8 dil and in 1989 all had titers >=8 dil, this difference is not statistically significant (P 0.2857); In the stillbirths that occurred in 2014 (2 cases), it was documented that they correspond to preterm pregnancies equal to what happened in 1989, but it is noteworthy that the pregnant women had attended one and two prenatal check-ups, respectively.

Taken and modified from: 14. Cifuentes CY, Currea GS, Espinel PA, Gutiérrez P MC, Lonngi RG, Muñoz RL, Ulloque G H. Syphilis – Prevalence in 1668 births. PEDIATRICS Volume 24 No. 1 1989 pages 46-49


In the Hospital where the 2 studies were carried out between 1989 and 2014, there has been a significant decrease in fetal mortality but fetal mortality caused by congenital syphilis persists and in 2014 abortions caused by CS are reported according to several studies [14,15]; fetal mortality due to syphilis persists worldwide as reported in a review in which it is estimated that in 2015 there were 2.6 million stillbirths, of which about 1.3 million of them could be prevented by antenatal care and highlights that although the determination of the origin of these deaths is not known with certainty due to the lack of records, for 18 countries with reliable data, congenital anomalies represent only 7.4% of fetal deaths, while maternal infections such as malaria and syphilis contribute in 8,

The cases of congenital syphilis in 2014 compared to 1989 show significant differences: absence of neonatal mortality due to CS, fewer premature babies and important changes in the clinical presentation of the disease with the absence of cases with manifestations detected on physical examination and a decrease in Serological titers of mothers and newborns with absence of VDRL reactivity in the CSF making the diagnosis of neurosyphilis difficult [16,17] since the findings in the CSF correspond to aseptic meningitis that can be caused by another agent [18,19]; furthermore, TPHA and FTA Abs are not routinely performed on CSF, which seem to have a higher sensitivity than VDRL [18,20].

The lower severity of the cases in the series in 2014 when compared to that of 1989 may be related to the decrease in the number of premature infants. The difference in the severity of systemic involvement in premature infants has previously been reported when contrasted with the involvement in term newborns [21].

This change in CS clinical features makes it necessary to demonstrate organ involvement by means of laboratory tests, as had been reported in a previous study [22], and despite the increase in the number of cases, it suggests a decrease in the pathogenicity of the treponema but retaining the ability to produce fetal mortality.

The surveillance program for gestational and congenital syphilis in our country is relatively recent, finding that this pathology was included within the mandatory notification events since 2003, prior to which no national records were found.

With the establishment of the active surveillance program for syphilis during pregnancy, it would be expected to find a reduction in congenital disease, and with this meet the objective of reducing its frequency to 0.5 cases or less per 1000 live births. In our study we found a prevalence of 0.841% in the population studied, with no statistically significant difference compared to that calculated 25 years ago, a fact that is reinforced by the National Institute of Health, which has reported an increase between the years 2016 and 2022. In congenital syphilis from 1.2 to 2.6 cases per 1,000 live births + stillbirths [11], a figure still far from the goal set in the millennium goals.

It should be noted as an encouraging finding, the evidence of a treatment success rate of 33%, which, although it is still below the projected goals, has changed when compared with the results obtained in 1989, a time in which no neither diagnosis nor treatment for syphilis was performed during pregnancy because the diagnosis was made at the time of delivery

This success rate in management could be better, the low number that is still observed is directly related to the quality of health promotion and disease prevention programs carried out in the country, as well as the effectiveness of the same in the early capture of all pregnant women, the early diagnosis of the pathology and its correct treatment, including within this the concomitant treatment of the partner in order to reduce reinfections. At this point we can conclude that in Colombia, despite the implementation several years ago of structured plans for the active search, detection and early treatment of gestational syphilis and prevention of congenital syphilis, these two pathologies continue to be public health problems. That is why it is necessary to optimize the programs that are in force, in order to improve both the success rate in the treatment of pregnant women with preconception disease, as well as the number of women infected during pregnancy and newborns. Compromised by congenital pathology. Likewise, general health education in terms of primary prevention of the disease in the entire population, including men and not only pregnant women, and the adequate training of medical personnel on the course, diagnosis and management of the same, become fundamental pillars.


1. de Cerqueira LRP, Monteiro DLM, Taquette SR, Nádia CP Rodrigues, Alexandre JB Trajano, Flavio Monteiro de Souza, et al. The magnitude of syphilis: from prevalence to vertical transmission. Rev Inst Med Trop São Paulo. 2017; 59: e78.

2. Arnold SR, Ford-Jones EL. Congenital syphilis: A guide to diagnosis and management. Pediatr Child Health. 2000; 5: 463-9.

3. Aleem S, Walker LS, Hornik CD, Smith MJ, Grotegut CA, Weimer KED. Severe Congenital Syphilis in the Neonatal Intensive Care Unit: A Retrospective Case Series. Pediatr Infect Dis J. 2022; 41: 335-339.

4. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396: 1204-1222.

5. Korenromp EL, Rowley J, Alonso M et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One. 2019; 14: e0211720.

6. Rosanna W. Peeling, David Mabey, Mary L. Kamb, Xiang-Sheng Chen, Justin D. Radolf, Adele S. Benzaken. Syphilis. Nat Rev Dis Primers. 2017; 3: 17073.

7. Stamm LV. Syphilis: Re-emergence of an old foe. Microb Cell. 2016; 3: 363-370.

8. Centers for Disease Control and Prevention Sexually transmitted diseases surveillance. 2020. Syphilis.

9. Choudhri Y, Miller J, Sandhu J, Leon A, Aho J. Infectious and congenital syphilis in Canada, 2010–2015. Can Commun Dis Rep. 2018; 44: 43-8.

10. Luppi CG, Tayra A, Domingues CSB, Gomes SEC, Pinto VM, Silva MAD, et al. Syphilis in the state of São Paulo, Brazil, 2011?2017. Rev Bras Epidemiol. 2020; 23: e200103.

11. National Institute of Health. Public Health Surveillance System. Communicable Diseases.

12. Temmerman M, Gichangi P, Fonck K, L Apers, P Claeys, L Van Renterghem, et al. Effect of a syphilis control program on pregnancy outcome in Nairobi, Kenya. Sex Transm Infect. 2000; 76: 117-21.

13. Evidence-based clinical practice guideline (CPG) for the comprehensive care of gestational and congenital syphilis.

14. Cifuentes CY, Currea GS, Espinel PA, Gutiérrez P MC, Lonngi RG, Muñoz RL, Ulloque G H. Syphilis – Prevalence in 1668 births. Pediatrics. 1989; 24: 46-49.

15. Lawn JE, Blencowe H, Waiswa P, Amouzou A, Mathers C, Hogan D et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet. 2016; 387: 587-603.

16. Izzat NN, Bartruff JK, Glicksman JM, Holder WR, Knox JM. Validity of the VDRL test on cerebrospinal fluid contaminated by blood. Br J Vener Dis. 1971; 47: 162-4.

17. Lukehart SA, Hook EW III, Baker-Zander SA, Collier AC, Crichlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109: 855-62.

18. Conde-Sendín MA, Hernández-Fleta JL, Cárdenes-Santana MA, AmelaPeris R. Neurosyphilis: forms of presentation and clinical management. Rev Neurol. 2002; 35: 380-6.

19. Cifuentes-Cifuentes Y, Tania Granadillo-Vásquez T. Usefulness of polymerase chain reaction in the diagnosis of congenital cytomegalovirus infection: about a case of aseptic meningitis. Infectious. 2015; 19: 175-178.

20. Najib Kissani N, Nafia S, Zahlane S, Louhab N. Neurosyphilis: a series of 178 cases at the 3rd-level hospital of Marrakesh (Morocco). Eur J Clin Microbiol Infect Dis. 2021; 40: 2129-2135.

21. Qinhua Zhou, Laishuan Wang, Chao Chen, Yun Cao, Weili Yan, Wenhao Zhou. A case series of 130 neonates with congenital syphilis: preterm neonates had more clinical evidences of infection than term neonates. Neonatology. 2012; 102: 152-6.

22. Vallejo C, Cifuentes Y. Characterization and six-month follow-up of a cohort of newborns with congenital syphilis. Biomedica. 2016; 36: 101-8.

Cifuentes-Cifuentes Y, Muñoz-Ramírez KJ (2022) Prevalence of Congenital Syphilis in a Hospital in Bogotá in 2014 and 25 Years Before. JSM Sexual Med 6(3): 1091.

Received : 30 May 2022
Accepted : 03 Aug 2022
Published : 05 Aug 2022
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X